Referencias:

Caffarelli C, G. M. (2016). Asthma and Food Allergy in Children: Is There a Connection or

Interaction? Frontiers in pediatrics , 5 (4), 34.

Cazzola M1, P. C. (2013). 2-agonist therapy in lung disease. Amercan Journal of respiratory and
critical care , 187 (7), 690-696.

Edelman JM, T. J. (2000). Oral montelukast compared with inhaled salmeterol to prevent
exercise-induced bronchoconstriction. Pubmed , 97-104.

Fireman, P. (2003). Understanding asthma pathophysiology. Allergy Asthma Proc. , 24 (2), 7983.

Given J, T. H. (2016, Jan. 29). Prospective, open-label evaluation of a new albuterol multidose
dry powder inhaler with integrated dose counter. Retrieved 3 26, 2016, from NCBI:
http://www.ncbi.nlm.nih.gov/pubmed/26831652
Hyrks H, I. T. (2016). Asthma control and cold weather-related respiratory symptoms. Respir
Med. , 1-7.

J, M., & L, Q. (2013). Psycopharmacology: drugs, the brain and behavior (2nd edition ed.).
Synauer.

Kew KM, D. K. (2016). Long-acting muscarinic antagonists (LAMA) added to combination longacting beta2-agonists and inhaled corticosteroids (LABA/ICS) versus LABA/ICS for adults with
asthma. the chocrane database , 1.

Kudo M, I. Y. (2013). Pathology of asthma. Frontiers in Microbiology , 4, 263.

Maslan J, M. J. (2014). What is asthma? Pathophysiology, demographics, and health care costs.

Otorynolaringologic clinics of north america , 47 (1), 13-22.
NIH. (2016, 2 15). Albuterol Oral Inhalation. Retrieved 3 24, 2016, from MEDLINE plus:
https://www.nlm.nih.gov/medlineplus/druginfo/meds/a682145.html
NIH. (2016, 3 24). Beta-2 adrenergic agonists. Retrieved 3 30, 2016, from NDDK:
http://livertox.nih.gov/Beta2AdrenergicAgonists.htm

O'Byrne PM, N. N. (2012). Severe asthma: future treatments. Clinical and experimental allergy:
British Journal , 706-711.


Paiva AC, M. F. (2014). Asthma: Gln27Glu and Arg16Gly polymorphisms of the beta2-adrenergic
receptor gene as risk factors. Allergy, asthma and clinical inmunology , 10 (1), 8.

R. R. (2016, marzo). Your body as a breathing machine. Dive training magazine , pp. 30-37.
Serrano, D. (2014, march 4). PRINCIPIOS ACTIVOS AGONISTAS Y ANTAGONISTAS. Retrieved from
farmaprofessionals: http://www.farmaprofesional.es/principios-activos-agonistas-yantagonistas/

Shimoda T, O. Y. (2016). Lung Sound Analysis and Airway Inflammation in Bronchial Asthma. J
Allergy Clin Immunol Pract. , 2213-2198.

Wechsler ME, Y. B., & Investigators., B. (2015). Anticholinergic vs Long-Acting -Agonist in
Combination With Inhaled Corticosteroids in Black Adults With Asthma: The BELT Randomized
Clinical Trial. JAMA , 314 (16), 1720-1730.
____